Stock Events

Stock Events

Next Science Limited 

A$0.145000
2
+A$0.00+3.57% Tuesday 23:14

Statistics

Day High
0.145
Day Low
0.14
52W High
0.155
52W Low
0.056
Volume
4,103,732
Avg. Volume
386,071
Mkt Cap
42.36M
P/E Ratio
-
Dividend Yield
200%
Dividend
0.29

Upcoming

Dividends

200%Dividend Yield
Feb 26
A$0.15
Feb 26
A$0.15
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

4MarExpected
Q4 2022
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.04
-0.03
-0.03
-0.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-46.29%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
72.44MRevenue
-33.54MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. competes in the surgical products sector, offering solutions that can overlap with Next Science's infection prevention technologies.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical technologies, including surgical equipment and orthopaedic devices, competing in the same space as Next Science.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc provides medical technologies, services, and solutions, including those for surgical wound management, directly competing with Next Science's offerings.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, potentially reducing the need for traditional surgical infection control products like those from Next Science.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the medical devices segment, offering a broad range of products that compete with Next Science's surgical infection prevention solutions.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops medical devices that are used in various surgical procedures, competing with Next Science's technology in infection management.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers medical devices and healthcare solutions that can compete with Next Science's products in the areas of wound care and surgical recovery.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a portfolio of healthcare products, including hospital and surgical products, which compete with Next Science's infection prevention technologies.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences Corporation specializes in heart and critical care products, which can overlap with Next Science's focus on surgical site infections.

About

Next Science Limited operates as an innovative medical technology company, committed to researching, developing, and commercializing advanced solutions that combat the detrimental effects of biofilms on human health in both the United States and Australia. The firm's product development is underpinned by its proprietary Xbio Technology platform. Its diverse portfolio includes SURGX, an antimicrobial gel designed for managing surgical infections; BACTISURE, a specialized wound lavage formulated to eliminate biofilm; BlastX, an antimicrobial wound gel that not only eradicates bacteria but also guards against recolonization, all while sustaining a moist healing environment; and XPERIENCE, a convenient, no-rinse antimicrobial solution aimed at preventing surgical site infections. Established in 2012, Next Science Limited is headquartered in Chatswood, Australia.
Show more...
CEO
Matthew Franco Myntti
Country
Australia
ISIN
AU0000041329

Listings

AU
AU
NXS.AU

0 Comments

Share your thoughts

FAQ

What is Next Science Limited stock price today?▼
The current price of NXS.AU is A$0.15 AUD — it has increased by +3.57% in the past 24 hours. Watch Next Science Limited stock price performance more closely on the chart.
What is Next Science Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Next Science Limited stocks are traded under the ticker NXS.AU.
Is Next Science Limited stock price growing?▼
NXS.AU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Next Science Limited has showed a +0% increase.
What is Next Science Limited market cap?▼
Today Next Science Limited has the market capitalization of 42.36M
What is Next Science Limited revenue for the last year?▼
Next Science Limited revenue for the last year amounts to 72.44M AUD.
What is Next Science Limited net income for the last year?▼
NXS.AU net income for the last year is -33.54M AUD.
Does Next Science Limited pay dividends?▼
Yes, NXS.AU dividends are paid en. The last dividend per share was 0.15 AUD. As of today, Dividend Yield (FWD)% is 200%.
In which sector is Next Science Limited located?▼
Next Science Limited operates in the Health & Wellness sector.
When did Next Science Limited complete a stock split?▼
Next Science Limited has not had any recent stock splits.
Where is Next Science Limited headquartered?▼
Next Science Limited is headquartered in Sydney, Australia.